ProShare Advisors
CHTP

ProShare Advisors’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

ProShare Advisors’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-79,410
Closed -$438K – 2792
2014
Q1 		$438K Buy
+79,410
New +$399K 0.01% 1973
2013
Q4 		– Sell
-42,377
Closed -$128K – 2410
2013
Q3 		$128K Buy
+42,377
New +$122K ﹤0.01% 2350

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

ProShare Advisors's CHTP Position: Q2 2014 in Review

ProShare Advisors sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 79,410 shares — an estimated $438K sold.

ProShare Advisors first reported a position in CHTP in Q3 2013 and held it in 2 quarters. The position peaked at $438K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • ProShare Advisors reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • ProShare Advisors sold 79,410 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $438K.
  • ProShare Advisors first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q3 2013 and held it in 2 quarters.
  • ProShare Advisors's CHELSEA THERAPEUTICS INT'L LTD position peaked at $438K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on ProShare Advisors's 13F filing for Q2 2014, filed 8 Aug 2014.